澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ISLAND PHARMACEUTICALS LTD

0.370

0.000

成交量：- -

成交额：- -

市值：1.09亿

市盈率：-10.16

高：0.370

开：0.370

低：0.370

收：0.370

52周最高：0.630

52周最低：0.310

股本：2.95亿

流通股本：1.11亿

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.036

每股收益(LYR):-0.036

净资产收益率：-95.50%

总资产收益率：-60.12%

市净率：8.10

市盈率(LYR):-10.16

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Island Pharmaceuticals Ltd：本财年未派发、建议或宣派股息

Island Pharmaceuticals携手Pi Health Sciences，追加生产GMP级Galidesivir

Island Pharmaceuticals股票交易暂停等待非洲埃博拉临床试验中Galidesivir使用情况公告

Island Pharmaceuticals启动Galidesivir GMP生产，以支持依据FDA动物规则路径的关键马尔堡病毒研究

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/ILA.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.37,"timestamp":1791848646546,"preClose":0.37,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":294766682,"eps":-0.0364,"marketStatus":"交易中","change":0,"latestTime":"10-13 10:59:16 AEDT","open":0.37,"high":0.37,"low":0.37,"amount":0,"amplitude":0,"askPrice":0.375,"askSize":17059,"bidPrice":0.37,"bidSize":21522,"shortable":3,"etf":0,"ttmEps":-0.0364,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791867600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.37,"openAndCloseTimeList":[[1791846000000,1791867600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ILA.AU","preClose":0.365,"auctionPrice":0.365,"auctionVolume":1500,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781207709}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-60.12%","roe":"-95.50%","lyrEps":-0.0364,"shares":294766682,"dividePrice":0,"high":0.37,"amplitude":0,"preClose":0.37,"low":0.37,"week52Low":0.31,"pbRate":"8.10","psRate":"385.85","week52High":0.63,"institutionHeld":0,"latestPrice":0.37,"committee":0.115679,"eps":-0.0364,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0364,"open":0.37,"prevYearClose":0.43,"prevWeekClose":0.365,"prevMonthClose":0.365,"prevQuarterClose":0.365,"fiveDayClose":0.365,"twentyDayClose":0.44,"sixtyDayClose":0.415,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1144643847","title":"Island Pharmaceuticals Ltd：本财年未派发、建议或宣派股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1144643847","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144643847?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 13:06","pubTimestamp":1787720769,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals Ltd 披露，在当前财务期间，公司既未派发股息，也未建议或宣派任何股息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126028723","title":"Island Pharmaceuticals携手Pi Health Sciences，追加生产GMP级Galidesivir","url":"https://stock-news.laohu8.com/highlight/detail?id=1126028723","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126028723?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 06:58","pubTimestamp":1787266689,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals已正式委托Pi Health Sciences，开展GMP级Galidesivir的追加生产工作。这一举措标志着该公司在抗病毒药物研发与供应链布局上迈出了关键一步。此次合作不仅强化了产能储备，也为后续临床及潜在商业化需求奠定了更坚实的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152078707","title":"Island Pharmaceuticals股票交易暂停 等待非洲埃博拉临床试验中Galidesivir使用情况公告","url":"https://stock-news.laohu8.com/highlight/detail?id=1152078707","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152078707?lang=zh_cn&edition=fundamental","pubTime":"2026-07-03 10:25","pubTimestamp":1783045517,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals Ltd  的股票交易已临时暂停，公司即将发布关于其抗病毒药物Galidesivir在非洲进行的埃博拉病毒病临床试验中应用情况的重要公告。此次交易暂停，预示着公司可能将披露与Galidesivir临床试验进展相关的关键信息。Galidesivir是一种广谱抗病毒核苷类似物，此前已被研究用于治疗多种病毒性疾病。市场正密切关注其在非洲针对埃博拉这一致命病毒的实际疗效数据。公告的发布，预计将为投资者评估该药物的研发前景及其对Island Pharmaceuticals未来价值的影响提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155692598","title":"Island Pharmaceuticals启动Galidesivir GMP生产，以支持依据FDA动物规则路径的关键马尔堡病毒研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1155692598","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155692598?lang=zh_cn&edition=fundamental","pubTime":"2026-06-04 07:05","pubTimestamp":1780527932,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals Ltd已启动抗病毒药物Galidesivir的GMP（良好生产规范）生产。此举旨在为一项关键的马尔堡病毒研究提供支持。该研究将依据美国食品药品监督管理局的“动物规则”路径进行。这一进展标志着公司在推进该候选药物治疗病毒性出血热方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ILA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}